Serelys Pharma

Sérélys Pharma is a leader in women's health, now launching Femaxeen®, a brand new patent-pending, natural solution for women’s urinary incontinence, documented by a randomized, double-blind, placebo-controlled study. This study documents that Femaxeen® significantly reduces women’s involuntary urine leaks versus placebo by over 45% within 2 months in all types of urinary incontinence (urge, stress and mixed), with no known side effects. Furthermore, Femaxeen® continues the company’s tradition of commercializing products based on exclusive, proprietary technology and this new product o...